IA
LMNL

IFP Advisors’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

IFP Advisors’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$1K – 4580
2022
Q4 		$1K Sell
1
-12
-92% -$55 ﹤0.01% 4556
2022
Q3 		$1K Hold
13
– – ﹤0.01% 4743
2022
Q2 		$1K Hold
13
– – ﹤0.01% 4510
2022
Q1 		$1K Buy
+13
New +$122 ﹤0.01% 4508

Other funds holding LMNL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

IFP Advisors's LMNL Position: Q1 2023 in Review

IFP Advisors sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2023, closing a stake of 1 share — an estimated $1K sold.

IFP Advisors first reported a position in LMNL in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2022. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

  • IFP Advisors reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 1 Liminal BioSciences Inc. Common Shares share in Q1 2023, an estimated $1K.
  • IFP Advisors first reported a position in Liminal BioSciences Inc. Common Shares in Q1 2022 and held it in 4 quarters.
  • IFP Advisors's Liminal BioSciences Inc. Common Shares position peaked at $1K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.